Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room: Disposals of own shares

INFORMATION REGLEMENTEE


[24/07/2020 | 20:01]
https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ek3NxbsYfQwU-2B6YdOOdmgXt6r-2BFGcdjhtQVXhutV-2BxEduhFWC=
rPyINgApb35plPcWbHEyQHDAuVSxWwjnrSHxbUnEUY_xDPID0vOuylFAU8fv4e60wei4JxqEGBd=
VWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9=
c9g1wb3-2BcnGmayQjQKsK5TiGxtyOlSLamRYiZw12Ml6RwAHDzGQjo9EagEaQXpM-2FfwaRgnw=
X9EC1BdoKz2DYZenVbLaT4HVKzSx2DS78fn8atuYfib8drA-2Fy2Yu0yq8ZlDfc-2BxPnJltEC8=
ydiTDJZhcLOg5eHrGwm3CPqCWvf2C8wtHhWPq5VFhpABTfFod558ImS76HW0Ws3dDZCe-2FV3q-=
2F3Nkf5lOx-2F4K9qvamcU8iiuU7ZgWJChOrvOrImxuZarI6mz4-3D

** Disposals of own shares
------------------------------------------------------------

Brussels (Belgium), 24 July 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulated=
information

In accordance with article 8:6 of the Royal Decree executing the Belgian Co=
de of Companies and Associations, UCB announces that, following exercises o=
f stock options by members of its personnel, it has disposed of UCB shares =
OTC in view of deliveries of these shares to the relevant members of the pe=
rsonnel, within the framework of the Long Term Incentive Program of the UCB=
Group, as follows:

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513=
9PTmAm2ORJ-2Fb7C-2B6ek3NxbsYfQwU-2B6YdOOdmgXtlQ0td4ggXwhMj3-2Fs2XUxpcOUwtO2=
ANLcH0Tb3OZi2MHrxEugUbgPceTi56JpJSL7n22v_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW=
u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9=
g1wb3-2BcnGmayQjQKsK5TiGxtyOlSLamRYiZw12Ml6RwAHDzGQjo9EagEaQXpM-2FfwaRgnwX9=
EC1BdoKz2DYZenVbLaT4HVKzSx2DS78fn8atuYfhZf2MDau87lKaR8vHdYmmVwM6UXv8tprM03S=
b7qxs6l-2BUzxMPVwzHUthiwoJGehpWzeifRZJNoo0S2nnHa-2BIXJ-2BV6XQHzUfHZyoMQSeWq=
ilNajvPxwhRhAVc50vDFZGI-2Bkp7xl-2F0F8VwZfpLL1iz50-3D
=C2=A0
This press release is available on UCB SA/NV=E2=80=99s website via the foll=
owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ=
yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1=
8dK5MiuQ-3D-3DtkSB_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS=
l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wb3-2BcnGmayQjQKsK5T=
iGxtyOlSLamRYiZw12Ml6RwAHDzGQjo9EagEaQXpM-2FfwaRgnwX9EC1BdoKz2DYZenVbLaT4HV=
KzSx2DS78fn8atuYfvFeI9K66UiBknCGbwAie9R5yENQQRujAiQ8pTtA5-2BozNilXFrali33aw=
hFnbwYjG5GM8hZYuFj2eTeWAU1BvYV-2FOGby354udKELUoDmKLevLFFBhrY9xPmY70vIVL5R84=
tQakmdoYseqwmdId7Emfo-3D .

Investor Relations
Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0
Investor Relations, UCB
T +32.2.559.94.14 antje.witte@ucb.com

Isabelle Ghellynck,
=C2=A0Investor Relations, UCB
T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company =
focused on the discovery and development of innovative medicines and soluti=
ons to transform the lives of people living with severe diseases of the imm=
une system or of the central nervous system. With 7 500 people in approxima=
tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i=
n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit=
ter: @UCB_news
=C2=A0
GenericFile
200724 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/=
ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek3NxbsYfQwU-=
2B6YdOOdmgXth0rhRLSb8HngjatE1gBJiPKLjuFkv6J5FC5JelT8Bqg-3DjFZN_xDPID0vOuylF=
AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2=
FOeoCOG9ekocVj-2F2X9c9g1wb3-2BcnGmayQjQKsK5TiGxtyOlSLamRYiZw12Ml6RwAHDzGQjo=
9EagEaQXpM-2FfwaRgnwX9EC1BdoKz2DYZenVbLaT4HVKzSx2DS78fn8atuYfpdj1iPF31Ryzup=
UdALY6GyHBhR56sI5pjt23FHPDAHk4-2BZMufeZG5qLAf0e1WnJDqR0e55R8xXbAtBTUH-2FuG4=
0bJ5JP8px1DXE0f73In-2BIi3EbOcoRbZ4SrqB-2Fd415F7in4LKlIkep4aCwLT-2F1V9sA-3D =
GenericFile
200724 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.ne=
t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek3NxbsYfQw=
U-2B6YdOOdmgXtZpsegqTufkgzbHoxCN9EQOiXSFFiqFpZqRDG87inDlE-3DjlpF_xDPID0vOuy=
lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf=
-2FOeoCOG9ekocVj-2F2X9c9g1wb3-2BcnGmayQjQKsK5TiGxtyOlSLamRYiZw12Ml6RwAHDzGQ=
jo9EagEaQXpM-2FfwaRgnwX9EC1BdoKz2DYZenVbLaT4HVKzSx2DS78fn8atuYfjkVo9dk8RpRm=
qc0IEdJzDKkYsnZjwUhZx0YA9vqLAvqOqh5GLW7FYhe9kMZdAbnw4HXnD4mBspS9S8MKCeFmNMi=
uYcR3HexIfTLii3x8yKIDrkZ8Ryc9G0piDnTxPPRSL38ZaSn1pTpAretbgCZbpo-3D GenericF=
ile
200724 - UCB Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/c=
lick?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek3NxbsYfQwU-2B6Y=
dOOdmgXtYBj6XOohN7Y-2BNt0wiNNoBWgeTGIAdQPcKOpfWKZRuiM-3DmTfy_xDPID0vOuylFAU=
8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO=
eoCOG9ekocVj-2F2X9c9g1wb3-2BcnGmayQjQKsK5TiGxtyOlSLamRYiZw12Ml6RwAHDzGQjo9E=
agEaQXpM-2FfwaRgnwX9EC1BdoKz2DYZenVbLaT4HVKzSx2DS78fn8atuYfhVShKmuQuZoaeNkL=
PDkZRcUXwDfSaJX6OF85kTTeSWW5jimdyCLp37-2BAz6JtUQjpHkQrxpdnvy2ltpxxamQwKfPOS=
hcw6Z4rmUkNYcyG6mDBfKMPb5NqYiDnD8Z77L-2BehKmRM1XrTzSa5smr00TVbk-3D Image
Chart 1 July 24 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED=
-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6ek3NxbsYfQwU-2B6YdOOdmgXtlQ0td4gg=
XwhMj3-2Fs2XUxpXB-2BCAe4lwDBUYN1HaEGM-2Bs-3Dira2_xDPID0vOuylFAU8fv4e60wei4J=
xqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj=
-2F2X9c9g1wb3-2BcnGmayQjQKsK5TiGxtyOlSLamRYiZw12Ml6RwAHDzGQjo9EagEaQXpM-2Ff=
waRgnwX9EC1BdoKz2DYZenVbLaT4HVKzSx2DS78fn8atuYfsjUO9PdBwQFL754TSa0d8BgOqcQ5=
IDdihIeuRRchmgLV6XHGW8vL6YXUniy-2FnNFjJ73E7TxDZi8TUwyMM3IZW5WsGRTtLtOjA2wdp=
Mmk4R0Ku8pfIuZ-2B4qdIbJg1pmq0-2BIqWbT3L8zY2F-2BbOcjhrYI-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT=
UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXudR8pdv4Xa3cp9EFsCQMqpt2V43ETT5=
1Br-2B4yci1BDmTu0UfyNiUgxu4j60K79PPvTjj5QpypYdKe0Ez4ryzqortRXju9Z7fO58eT05J=
7hY-3DjjwW_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6=
EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wb3-2BcnGmayQjQKsK5TiGxtyOlS=
LamRYiZw12Ml6RwAHDzGQjo9EagEaQXpM-2FfwaRgnwX9EC1BdoKz2DYZenVbLaT4HVKzSx2DS7=
8fn8atuYfrlfWSVqTWkxm6m7LTXWRRhVm1KZiyC-2FE8M8MQBHC2ZYGXmp4CVDYNscqdAcKFl8f=
PN5UGYrP4iraxgI-2FIOJ8Lx5A620iX4aqfHCtXvjOShO7-2F7fT-2BSq4EMPYLwIaGeNqdacQg=
QdrU8QjmU1weUgvbc-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=